Form 4: Abeona Therapeutics Director Mark Alvino Sells 4,000 Shares

Director Mark Alvino of Abeona Therapeutics sold 4,000 shares of common stock at an average price of $5.38 on January 29, 2025.

Summary

• On January 29, 2025, Mark Alvino, a director of Abeona Therapeutics Inc., sold 4,000 shares of the company's common stock.
• The shares were sold at a weighted average price of $5.38.
• The sales occurred in multiple transactions with prices ranging from $5.35 to $5.41.
• Following the transaction, Alvino directly owns 64,334 shares of Abeona Therapeutics.
• This transaction was reported on a Form 4 filing with the SEC on January 31, 2025.

Sentiment

Score: 5

Explanation: This is a neutral event. A director selling shares doesn't necessarily indicate a negative outlook, but it also doesn't provide a positive signal.

Industry Context

This is a routine disclosure of insider trading activity. It's common for directors and officers of publicly traded companies to buy and sell shares of their company's stock. The reasons for these transactions can vary widely and may not necessarily reflect a change in the director's outlook for the company.

Stakeholder Impact

• The sale of shares by a director could have a minor impact on shareholder sentiment.

Key Dates